ApoE expression in glomerulus and correlation with glomerulosclerosis induced by adriamycin in rats

Renal Failure

Volumn 33, Issue 3, 2011, Pages 348-354

  Zhou, Tian Biao ^a   Qin, Yuan Han ^a   Lei, Feng Ying ^a   Su, Li Na ^a   Zhao, Yan Jun ^a   Huang, Wei Fang ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein E; extracellular matrix; glomerulosclerosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; APOENZYME; COLLAGEN TYPE 4; CREATININE; DOXORUBICIN; FIBRONECTIN; MESSENGER RNA; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; UREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; GLOMERULUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; UPREGULATION; UREA NITROGEN BLOOD LEVEL;

ACTINS; ANIMALS; APOLIPOPROTEINS E; COLLAGEN TYPE IV; DOXORUBICIN; EXTRACELLULAR MATRIX; FIBRONECTINS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; MALE; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 79952676685     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.559680     Document Type: Article

References (28)

1. Attila G, Noyan A, Karabay BA, Acarturk E, Anarat A. Apoli-poprotein E polymorphism in childhood nephrotic syndrome. Pediatr Nephrol. 2002;17:359-362. (Pubitemid 36076053)
2. Hu P, Qin YH, Lu L, Hu B, Jing CX, Lei FY. Genetic varia-tion of apolipoprotein E does not contribute to the lipid abnor-malities secondary to childhood minimal change nephrotic syndrome. Int Urol Nephrol. 2010;42:453-460.
3. Chen G, Paka L, Kako Y, Singhal P, Duan W, Pillarisetti S. A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion. J Biol Chem. 2001;276:49142-49147.
4. Zhang Y, Yasumoto Y, Ikeda T, Takenouchi S, Sogabe A, Nosaki T. Apolipoprotein E regulates primary cultured human mesangial cell proliferation. Nephron Exp Nephrol. 2006;102:62-70.
5. Calandra S, Gherardi E, Fainaru M, Guaitani A, Bartosek I. Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental neph-rotic syndrome. Biochim Biophys Acta. 1981;665:331-338. (Pubitemid 12232501)
6. Deighan CJ, Caslake MJ, McConnell M, Boulton-Jones JM, Packard CJ. Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1. Kidney Int. 2000;58:1238-1246.
7. Russi G, Furci L, Leonelli M, Magistroni R, Romano N, Rivasi P. Lipoprotein glomerulopathy treated with LDL-aph-eresis (heparin-induced extracorporeal lipoprotein precipita-tion system): A case report. J Med Case Rep. 2009;3:9311.
8. Saito T, Sato H, Oikawa S. Lipoprotein glomerulopathy: A new aspect of lipid induced glomerular injury. Nephrology. 1995;1:17-24.
9. Raij L, Azar S, Keane W. Mesangial immune injury, hyperten-sion, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26:137-143. (Pubitemid 14017051)
10. Dai C, Stolz DB, Bastacky SI, St-Arnaud R, Wu C, Dedhar S. Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol. 2006;17:2164-2175. (Pubitemid 44141906)
11. Hu P, Qin YH, Pei J, Lei FY, Hu B, Lu L. Beneficial effect of all-trans retinoic acid (ATRA) on glomerulosclerosis rats via the down-regulation of the expression of alpha-smooth muscle actin: A comparative study between ATRA and benazepril. Exp Mol Pathol. 2010;89:51-57.
12. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25:402-408. (Pubitemid 34164012)
13. Danilewicz M, Wagrowska-Danielwicz M. Morphometric and immunohistochemical insight into focal segmental glomeruloscle-rosis in obese and non-obese patients. Nefrologia. 2009;29:35-41.
14. Kaouthar M, Faical J, Abdelmajid K, Basma H, Mohamed BH, Hafedh M. Renal a-smooth muscle actin: A new prognos-tic factor for lupus nephritis. Nephrology. 2009;14:499-505.
15. Wang W, Liu F, Chen N. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profi-brotic response induced by TGF-beta1 in renal interstitial fibroblasts. Mediat Inflamm. 2007;2007:62641.
16. Adan VS, Javier AM, Marisol R, Jaime GM, Dolores UB, Rita GD. Association of polymorphisms within the transforming growth factor-b1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations. Nephrology. 2010; 15:644-648.
17. Yutaka K, Atsuhito N, Chisei RA, Ko O, Eri M, Hideoki O. Role of transforming growth factor-b/Smad signalling pathway in enhanced production of glomerular extracellular matrix in IgA nephropathy of high-serum-IgA ddY mice. Nephrology. 2002; 7:151-155.
18. Hakki A, Mehmet K, Fulya YC, Serhan T, Cetin O, Akoglu E. Histopathological changes and tumour necrosis factor-a, transforming growth factor-b and tenascin expression in patients with primary type I membranoproliferative glomeru-lonephritis in remission. Nephrology. 2009;14:219-226.
19. Lin CT, Xu YF, Wu JY, Chan L. Immunoreactive apolipopro-tein E is a widely distributed cellular protein. Immunohistochem-ical localization of apolipoprotein E in baboon tissues. J Clin Invest. 1986;78:947-958. (Pubitemid 17177075)
20. Grone HJ, Walli AK, Grone E, Kramer A, Clemens MR, Seidel D. Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells. Kidney Int. 1990;37:1449-1459. (Pubitemid 20198026)
21. Kaysen GA, der de Sain-van VM. New insights into lipid metabolism in the nephrotic syndrome. Kidney Int Suppl. 1999;71:18-21.
22. Kamanna VS, Bassa BV, Ganji SH. Low density lipoproteins transactivate EGF receptor: Role in mesangial cell prolifera-tion. Life Sci. 2008;83:595-601.
23. Hayashi K, Sasamura H, Ishiguro K, Sakamaki Y, Azegami T, Itoh H. Regression of glomerulosclerosis in response to tran-sient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2. Kidney Int. 2010;78:69-78.
24. Qin YH, Lei FY, Hu P, Pei J, Feng ZB, Pang YS. Effect of all-trans retinoic acid on renal expressions of matrix metallopro-teinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with glomerulosclerosis. Pediatr Nephrol. 2009;24:1477-1486.
25. Zhang W, Li Q, Wang L, Yang X. Simvastatin ameliorates glomerulosclerosis in adriamycin-induced-nephropathy rats. Pediatr Nephrol. 2008;23:2185-2194.
26. Zhou MS, Schuman IH, Jaimes EA, Raij L. Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. Am J Physiol Renal Physiol. 2008;295:53-59.
27. Chade AR, Zhu XY, Grande JP, Krier JD, Lerman A, Lerman LO. Simvastatin abates development of renal fibrosis in experimental renovascular disease. J Hypertens. 2008; 26:1651-1660.
28. Garcia-de-la-Puente S, Arredondo-Garcia JL, Gutierrez-Cas-trellon P, Bojorquez-Ochoa A, Maya ER, Perez-Martinez MP. Efficacy of simvastatin in children with hyperlipidemia second-ary to kidney disorders. Pediatr Nephrol. 2009;24:1205-1210.